An influential coalition of leading cancer charities, led by Prostate Cancer UK, has criticised the government for shutting patients out of crucial talks on changes to the UK-wide system for pricing and assessing new drugs. The cancer charities warn that ignoring the views of patients risks seriously undermining the credibility and effectiveness of the new system before it has even been established.

Read more